Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News on Pharma

Gilead Topples On A Surprise Setback For Its 99.9% Effective HIV Drug

Gilead stock toppled Thursday on a report CVS won't add the company's new HIV prevention drug, Yeztugo, to its commercial plans for now.

Investors Business Daily

IBD Rating Upgrades: Takeda Pharmaceutical ADR Shows Improved Technical Strength

Takeda Pharmaceutical ADR shows rising price performance, earning an upgrade to its IBD Relative Strength Rating

Investors Business Daily

Who Is Anna Bouyzk? Woman Attacks Neighbour with Anti-Semitic Slurs and Said His Dead Daughter Deserved To Die

Anna Bouyzk, wife of biotech entrepreneur Mark Bouzyk, is accused of hurling anti-Semitic slurs at her neighbour David Lubin, whose daughter, a 20-year-old IDF soldier, was killed in Jerusalem.

International Business Times UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Health Care Stock Flashes Golden Cross As Sales Surge; Shares Hover Near Buy Point

Health care stock Medpace Holdings soared to an all-time high after second-quarter results. Shares are in a 5% buy zone,.

Investors Business Daily

Novo Nordisk Rallied On Wegovy's Newest Approval. But This Rival Rallied More.

Novo Nordisk stock jumped Monday after the FDA approved the company's obesity drug, Wegovy, as a treatment for MASH.

Investors Business Daily

Ozempic sales surge ‘up to 600%’ after Mounjaro price rises

Price hikes are 'kick in the teeth' for patients who will either have to swallow 170 per cent price increase, or switch to 'almost as good' competitor

The Independent UK

Voices: Pricing people out of using Mounjaro would be bad news for the NHS

COMMENT: The astronomical rise in weight-loss drug prices caused by Trump’s tariffs could have a significant – and dangerous – impact on Britain’s pharmacies and patients, writes Leyla Hannbeck, CEO of the Independent Pharmacies Association

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Stock Market Rallies Amid Shifts Despite Hot Inflation; Amazon, CoreWeave In Focus: Weekly Review

The stock market had a strong week despite hot inflation, but with shifts underneath. Amazon jumped on a grocery delivery push.

Investors Business Daily

‘Close for a day so we don't close forever’: French pharmacies to go on strike

Pharmacists across France are staging a one-day protest on Saturday, warning that government cuts to generic drug discounts could spell the end for many of their businesses.

Radio France Internationale

Bioethanol plant deems lack of Government support an ‘act of economic self-harm’

Vivergo Fuels says it will have to close its Hull plant after the decision not to provide financial backing.

Evening Standard

Lyme Disease Is Spiking. This Biotech Nears A Treatment And A Buy Point.

This biotech is nearing a buy point of a cup base. The company has a treatment for Lyme disease in its pipeline.

Investors Business Daily

Sarepta Sells Arrowhead Stake To Stretch Its Cash Runway; And One Stock Dives

Arrowhead Pharmaceuticals stock tumbled Thursday after Sarepta Therapeutics liquefied its entire stake in the smaller biotech company.

Investors Business Daily

Argentina rocked as contaminated medical fentanyl kills up to 96 patients

Dozens of hospital patients treated with opioid for unrelated conditions suffered serious bacterial infections

The Guardian - US

Zevra Therapeutics Crashes, Reversing 89% Run. Why It Could Be An 'Overreaction.'

Zevra Therapeutics stock crashed Wednesday in what one analyst called an "overreaction" to issues surrounding its acquired drug, Olpruva.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Liquidia Shoots Higher As Yutrepia Launch Kicks Off Amid United Patent Battle

Liquidia stock shot higher Tuesday after its new drug, Yutrepia, widely beat prescription and patient start expectations.

The Independent UK

Attorney says heart device did not shock Tennessee man in execution who said he was 'hurting so bad'

The attorney for a Tennessee man who said he was “hurting so bad” during his lethal injection this week says his implanted defibrillator did not shock him

Investors Business Daily

Gilead Surges 8%, Flirting With A Breakout, On Growing Enthusiasm For HIV PrEP

Gilead stock briefly broke out Friday after the biotech company beat second-quarter forecasts amid its newest launch in HIV prevention.

The Independent UK

‘Shock’ as study reveals how weight-loss pill stacks up against injections

Shares in a pharmaceutical company plummeted after the results were made public

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Eli Lilly Dives 14% On A Shocking Obesity Setback, Sending Its Rivals Flying

Eli Lilly stock tumbled Thursday on an unexpected setback for its obesity franchise, sending shares of its rival flying.

Investors Business Daily

This Cancer Treatment Stock Nears A Buy Point As Quarterly Results Loom

Zai Lab stock is in a cup-with-handle base before Q2 results due Thursday.

The Guardian - UK

Shares in European drug companies hit four-month low as Trump tariffs loom

President repeats threat to bring in levies ‘within next week or so’ in attempt to get companies to move production to US

Evening Standard

Fake Viagra is the UK’s most seized counterfeit drug - here's how to avoid it

Fake Viagra, real problems – the UK’s most seized counterfeit drug revealed

Kiplinger

Ozempic, Botox, Eliquis: How Tariffs on Europe Could Impact Drug Prices (And What To Do About It)

Most medications come from Europe. Does that mean the new tariffs on the EU will drive drug prices higher?

Investors Business Daily

Why S&P 500 Stock Amgen Stumbled Despite Its Beat-And-Raise Quarter

Amgen stock dropped Wednesday despite a strong second quarter as investors look ahead to the next weight-loss readouts.

Investors Business Daily

Inspire Medical Systems Crashes 32% As Eli Lilly's GLP-1 Weighs On Guidance

Inspire Medical Systems crashed Tuesday after the maker of implantable sleep apnea devices called out GLP-1 drugs for weighing on sales.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Investor Business Daily

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.